Five metachronous primary malignant tumors in a young female with a TP53 p.R273H variant: a case report of suspected Li-Fraumeni syndrome

Multiple primary malignant tumors (MPMTs) are relatively rare among patients with malignancies, and the occurrence of five metachronous primary cancers in the same patient is even rarer. Here, we report a case of a 42-year-old female patient who was diagnosed with five metachronous MPMTs over a span of 13 years, in chronological order: right breast cancer (2013), right lung adenocarcinoma (2018), left ovarian mucinous adenocarcinoma (2024), gastric poorly cohesive carcinoma (2025), and left breast cancer (2026). Tumor tissue testing of the ovarian cancer revealed a classical pathogenic variant of TP53 (p.R273H). Combined with her clinical phenotype meeting the Chompret criteria, she was clinically suspected to have Li-Fraumeni syndrome (LFS); however, peripheral blood validation was not performed, so the germline status remains unconfirmed. Molecular profiling identified PIK3CA H1047L, PTEN R130Q, and E157* mutations in the ovarian cancer; an EGFR L858R mutation in the lung cancer; and HER2 positivity (IHC 3+) in the left breast cancer. This case highlights that in patients with early-onset breast cancer (particularly < 46 years of age) and those with multiple primary malignancies, a high index of suspicion for hereditary cancer predisposition syndromes should be maintained. Timely genetic testing, including comprehensive germline validation, is essential to enable individualized surveillance, treatment, and familial genetic counseling.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-18
DOI
https://doi.org/10.3389/fonc.2026.2011074
Primary Topic
Multiple and Secondary Primary Cancers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Five metachronous primary malignant tumors in a young female with a TP53 p.R273H variant: a case report of suspected Li-Fraumeni syndrome

Ming Yang, Yiwen Li, Meimei Ren, Cuicui Geng
3 links
Frontiers in Oncology
Multiple and Secondary Primary Cancers
article

Five metachronous primary malignant tumors in a young female with a TP53 p.R273H variant: a case report of suspected Li-Fraumeni syndrome

Ming Yang, Yiwen Li, Meimei Ren, Cuicui Geng
article en

Abstract

Multiple primary malignant tumors (MPMTs) are relatively rare among patients with malignancies, and the occurrence of five metachronous primary cancers in the same patient is even rarer. Here, we report a case of a 42-year-old female patient who was diagnosed with five metachronous MPMTs over a span of 13 years, in chronological order: right breast cancer (2013), right lung adenocarcinoma (2018), left ovarian mucinous adenocarcinoma (2024), gastric poorly cohesive carcinoma (2025), and left breast cancer (2026). Tumor tissue testing of the ovarian cancer revealed a classical pathogenic variant of TP53 (p.R273H). Combined with her clinical phenotype meeting the Chompret criteria, she was clinically suspected to have Li-Fraumeni syndrome (LFS); however, peripheral blood validation was not performed, so the germline status remains unconfirmed. Molecular profiling identified PIK3CA H1047L, PTEN R130Q, and E157* mutations in the ovarian cancer; an EGFR L858R mutation in the lung cancer; and HER2 positivity (IHC 3+) in the left breast cancer. This case highlights that in patients with early-onset breast cancer (particularly < 46 years of age) and those with multiple primary malignancies, a high index of suspicion for hereditary cancer predisposition syndromes should be maintained. Timely genetic testing, including comprehensive germline validation, is essential to enable individualized surveillance, treatment, and familial genetic counseling.

Frontiers in OncologyVol. 16
Guangzhou University of Chinese Medicine (CN), Beijing University of Chinese Medicine (CN), Affiliated Hospital of Shaanxi University of Chinese Medicine (CN), Shaanxi University of Chinese Medicine (CN)
Good health and well-being
Multiple and Secondary Primary Cancers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon